Clinical Trial Update: Efficacy and Safety of Lubiprostone in the Treatment of Slow Transit Constipation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating lubiprostone for slow transit constipation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Slow-transit Constipation

Drugs mentioned

• Amitiza (lubiprostone)

Snippet

Sponsor: Third Military Medical University | Conditions: Slow Transit Constipation, Pharmacotherapy | Phase 3 | Status: RECRUITING